In 1893, a German scientist made a striking discovery: Cells from a fetus hide out in a mother’s body after birth. Scientists say these cells alter the risk of breast…
www.npr.org|By Morning Edition
Foeto-maternal Microchimerism and Autoimmunity.
Microchimerism
en.wikipedia.org
Emmanuel, God with us. Blessed Christmas, everyone!
Mesenchymal Stem Cell-Based Therapy in Lupus & Scleroderma
arthritis-research.biomedcentral.com
Failure of mesenchymal stem cells in GVHD – is devil in the cell prep?
As we all know, Phase III clinical trial, sponsored by Osiris Therapeutics and assessed efficacy of…
stemcellassays.com
Has Osiris’ Prochymal, one of the most promising immunomodulatory stem cell product trialed for GvHD and Crohn’s in the last decade, finally bitten the dust?
NEW YORK and MELBOURNE, Australia, April 28, 2014 (GLOBE NEWSWIRE) — Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today provided an update on its clinical programs using the product Prochymal®, which was acquired as part of the entire culture-expanded mesenchymal stem cell…
globenewswire.com|By Mesoblast
White Knight Mesoblast holds out hope for Prochymal in Crohn’s, even GvHD, perhaps other refractory rheumatic diseases as well! Stem cell therapy may well pave the way for Rheumatology to advance into the era of Regenerative Medicine.